Veracyte (VCYT) Competitors $27.64 -1.17 (-4.06%) Closing price 03:59 PM EasternExtended Trading$27.60 -0.05 (-0.16%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VCYT vs. OPCH, GH, RDNT, BTSG, SHC, PRVA, SGRY, CON, LFST, and ARDTShould you be buying Veracyte stock or one of its competitors? The main competitors of Veracyte include Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry. Veracyte vs. Option Care Health Guardant Health RadNet BrightSpring Health Services Sotera Health Privia Health Group Surgery Partners Concentra Group Holdings Parent LifeStance Health Group Ardent Health Partners Veracyte (NASDAQ:VCYT) and Option Care Health (NASDAQ:OPCH) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, community ranking, valuation, profitability, risk, earnings, institutional ownership and media sentiment. Do insiders & institutionals have more ownership in VCYT or OPCH? 98.1% of Option Care Health shares are owned by institutional investors. 1.4% of Veracyte shares are owned by insiders. Comparatively, 0.6% of Option Care Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is VCYT or OPCH more profitable? Option Care Health has a net margin of 4.37% compared to Veracyte's net margin of -2.18%. Option Care Health's return on equity of 15.30% beat Veracyte's return on equity.Company Net Margins Return on Equity Return on Assets Veracyte-2.18% 3.02% 2.80% Option Care Health 4.37%15.30%6.57% Which has more volatility and risk, VCYT or OPCH? Veracyte has a beta of 2.14, suggesting that its stock price is 114% more volatile than the S&P 500. Comparatively, Option Care Health has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Does the MarketBeat Community prefer VCYT or OPCH? Veracyte received 388 more outperform votes than Option Care Health when rated by MarketBeat users. Likewise, 73.14% of users gave Veracyte an outperform vote while only 64.00% of users gave Option Care Health an outperform vote. CompanyUnderperformOutperformVeracyteOutperform Votes45273.14% Underperform Votes16626.86% Option Care HealthOutperform Votes6464.00% Underperform Votes3636.00% Do analysts rate VCYT or OPCH? Veracyte presently has a consensus price target of $40.90, indicating a potential upside of 47.97%. Option Care Health has a consensus price target of $35.50, indicating a potential upside of 8.46%. Given Veracyte's higher possible upside, equities analysts clearly believe Veracyte is more favorable than Option Care Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veracyte 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Option Care Health 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88 Which has higher earnings and valuation, VCYT or OPCH? Option Care Health has higher revenue and earnings than Veracyte. Option Care Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeracyte$463.39M4.67-$74.40M$0.4167.41Option Care Health$5.19B1.03$267.09M$1.2426.40 Does the media favor VCYT or OPCH? In the previous week, Veracyte had 3 more articles in the media than Option Care Health. MarketBeat recorded 15 mentions for Veracyte and 12 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.81 beat Veracyte's score of 1.30 indicating that Option Care Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Option Care Health 12 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryOption Care Health beats Veracyte on 10 of the 18 factors compared between the two stocks. Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCYT vs. The Competition Export to ExcelMetricVeracyteMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.16B$2.91B$5.36B$8.39BDividend YieldN/A31.24%5.22%4.10%P/E Ratio-184.2712.9026.5919.72Price / Sales4.67160.47391.61116.20Price / Cash442.2957.5638.2534.62Price / Book1.934.266.794.51Net Income-$74.40M-$22.21M$3.23B$248.18M7 Day Performance-2.98%3.15%4.03%1.14%1 Month Performance-9.67%5.72%12.22%15.07%1 Year Performance26.91%1.43%16.76%6.59% Veracyte Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCYTVeracyte3.9942 of 5 stars$27.64-4.1%$40.90+48.0%+29.2%$2.16B$463.39M-184.27790News CoverageGap UpOPCHOption Care Health3.5937 of 5 stars$33.09-0.4%$35.50+7.3%+13.8%$5.42B$5.19B27.815,600Positive NewsGHGuardant Health4.6875 of 5 stars$40.24-1.1%$52.32+30.0%+61.4%$4.99B$774.00M-11.301,790Positive NewsRDNTRadNet3.4035 of 5 stars$60.66-0.8%$69.75+15.0%+2.9%$4.55B$1.87B-866.458,970BTSGBrightSpring Health Services1.6561 of 5 stars$24.11-1.3%$23.56-2.3%+108.0%$4.20B$11.86B-92.7335,000Positive NewsGap UpSHCSotera Health2.1906 of 5 stars$12.74-0.5%$15.80+24.0%+15.6%$3.62B$1.11B50.963,000Gap UpPRVAPrivia Health Group3.6569 of 5 stars$25.00-0.1%$27.38+9.5%+52.4%$3.05B$1.80B250.03810SGRYSurgery Partners2.8012 of 5 stars$23.60-1.4%$34.75+47.2%-8.9%$3.02B$3.17B-49.1712,200Positive NewsCONConcentra Group Holdings ParentN/A$22.54-0.8%$28.50+26.4%N/A$2.87B$1.93B16.8211,000Gap UpLFSTLifeStance Health Group2.3872 of 5 stars$5.84flat$8.30+42.1%-22.4%$2.27B$1.28B-22.466,640ARDTArdent Health Partners3.2244 of 5 stars$15.09-2.1%$20.75+37.5%N/A$2.16B$6.02B9.2624,200Analyst Forecast Related Companies and Tools Related Companies Option Care Health Competitors Guardant Health Competitors RadNet Competitors BrightSpring Health Services Competitors Sotera Health Competitors Privia Health Group Competitors Surgery Partners Competitors Concentra Group Holdings Parent Competitors LifeStance Health Group Competitors Ardent Health Partners Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCYT) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
